Patient Group and Members of the Public Disclosures

Patient Groups – or patient advocacy groups and patient organisations – are important partners for Stirling Anglian Pharmaceuticals. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community. We support patient organisations in our therapeutic areas through sponsorships, grants and donations. 

In keeping with our commitment to ensure responsible business practices, Stirling Anglian Pharmaceuticals believes transparency in our funding decisions is vital to building and maintaining trust with our stakeholders. 

Patient Groups

Association of the British Pharmaceutical Industry (ABPI) Disclosure Code Reports 

The Association of the British Pharmaceutical Industry (ABPI) believes that interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research and therefore, requires transparency to these interactions through the ABPI code of practice.

Stirling Anglian Pharmaceuticals supports the principles of transparency put forth by the ABPI and is committed to ensuring we meet the highest degree of integrity expected by our patients, healthcare professionals, healthcare organisations and other stakeholders.